Skip to content
Nonprofiteer
← PHILLIPS-AMICK FOUNDATION FOR CANCER RESEARCH

Form 990 for tax year 2024

Filed by PHILLIPS-AMICK FOUNDATION FOR CANCER RESEARCH.

Totals

Total revenue
$456,755
Total expenses
$504,958
Contributions and grants received
$456,755
Grants paid
$0
Program service revenue
$0
Investment income
$0
Other revenue
$0
Total assets, end of year
$41,395
Total liabilities, end of year
$0
Net assets or fund balances, end of year
$41,395
Program services expenses (Part IX)
$504,058
Management and general expenses
$900
Fundraising expenses
$0
Program service expenses (Part III)
$504,058

Program services were 99.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $456,755

Functional expenses

Part IX, the statement of functional expenses.

  • 11c · Fees: accounting

    total $900 · management and general $900

  • 24a · Other expenses: BASKET TRIAL EXPENSE

    total $504,058 · program services $504,058

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $89,598 · end of year $41,395

  • 27 · Net assets without donor restrictions

    beginning of year $89,598 · end of year $41,395

Mission and programs · 2024

Mission

AT THE PHILLIPS-AMICK FOUNDATION FOR CANCER RESEARCH, WE ENVISION A FUTURE WHERE MEDICAL BREAKTHROUGHS ARE COMMONPLACE AND ACCESSIBLE TO ALL. WE STRIVE TO MAKE A POSITIVE IMPACT ON THE LIVES OF PATIENTS AND THEIR FAMILIES THROUGH OUR WORK IN CANCER RESEARCH AND DEVELOPMENT.

  • ELIOS HOLDINGS IS CONDUCTING AN FDA SANCTIONED PHASE I/2A "BASKET TRIAL" IN GREENVILLE, SC TESTING ITS PROPRIETARY THERAPEUTIC CANCER VACCINE ACROSS A WIDE RANGE OF CANCER TYPES. THE ELIOS TECHNOLOGY INCORPORATES THE CANCER PATIENTS' OWN TUMOR INTO A THERAPEUTIC CANCER VACCINE ADMINISTERED THROUGH A SERIES OF SIX INTERDERMAL INJECTIONS.

    Expenses $504,058 · Revenue $456,755

As filed on the 2024 return.

Listed in Part VII

  • Riley Polk

    CHAIRMAN

    Total calculated
    $0
    Hours/week
    1

  • James Roquemore

    VICE-CHAIRMAN

    Total calculated
    $0
    Hours/week
    1

  • Alton C Phillips Sr

    SECRETARY/TREASURER

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2024
Filed
30 April 2025
IRS schema version
2024v5.1
Source object
202501299349303115

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.